Total Return chart Regeneron Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-08 EDT			5-day change	1st Jan Change
810.31 ^USD	-2.10%		+1.41%	+4.98%

09-01	Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says	MT
08-28	Regeneron Pharmaceuticals Inc Initiates Recall of Libtayo (Cemiplimab-Rwlc) Injection, 350 Mg/7 Ml (50 Mg/Ml) For Intravenous Infusion After Dilution, Single-Dose Vial	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.